Related Experiment Video
Updated: Jul 18, 2026
09:47
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
Fluorocarbon nanoparticles as multifunctional drug delivery vehicles
1Department of Pharmaceutics and Pharmaceutical Chemistry, Department of Bioengineering, University of Utah, Salt Lake City, UT 84108, USA. bruce.yu@utah.edu
Journal of Drug Targeting
|December 13, 2006
Summary
Fluorocarbon nanoparticles offer advanced drug delivery by integrating with MRI for real-time monitoring of drug distribution. This enables personalized treatment adjustments based on patient response.
Area of Science:
- Biomedicine
- Nanotechnology
- Drug Delivery
Background:
- Fluorocarbon nanoparticles (FCNPs) are emerging as versatile tools in biomedicine.
- Current FCNP formulations have limitations that hinder their widespread clinical application.
Purpose of the Study:
- To review the history and current status of FCNPs in biomedicine.
- To highlight deficiencies in existing FCNP formulations and propose strategies for improvement.
- To discuss the potential of functionalized FCNPs as multifunctional drug delivery vehicles.
Main Methods:
- Literature review of fluorocarbon nanoparticle research in biomedicine.
- Analysis of current formulation deficiencies and proposed functionalization strategies.
- Discussion of potential applications in drug delivery and medical imaging.
Main Results:
- Identified key limitations in current fluorocarbon nanoparticle formulations.
- Presented strategies for enhancing FCNP properties through functionalization.
- Highlighted the potential of FCNPs for integrated drug delivery and real-time biodistribution monitoring.
Conclusions:
- Fluorocarbon nanoparticles show significant promise as multifunctional drug delivery systems.
- The integration of drug delivery with non-invasive MR imaging allows for real-time monitoring of biodistribution.
- This capability enables personalized medicine by allowing physicians to adjust treatment plans based on individual patient responses.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...